A cleanroom or clean
room is an environment, typically used in manufacturing or scientific research
that has a low level of environmental pollutants such as dust, airborne microbes,
aerosol particles and chemical vapors. More accurately, a clean-room has a controlled
level of contamination that is specified by the number of particles per cubic
meter at a specified particle size.
Don’t
get confuse about 100 class clean room. Several regulatory agencies in this
world regulate the pharmaceutical industry. USFDA, MHRA, EU, TGA, WHO are few
major regulatory body those who regulate the major pharma market. Basic concept
is same but sometimes terminology or way of expression is different, so we
should clear about the idea of 100 Clean room concept. In pharma industry the
clean room concept mainly fit with parenteral division where the maintenance of
area and segregation between different areas is necessary to avoid cross
contamination and maintain sterility of product.
A Grade 100 clean-room is designed to never allow more than 100 particles (0.5
microns) per cubic foot of air. Class 1000 and Class 10,000 clean rooms are
designed to limit particles to 1000 and 10,000 respectively.
Now
a day’s current industry pattern is that, they avoid maximum particles/ft3
concept. Major guidelines and regulatory agency are giving their focus on
maximum particles/m3. As per
major regulatory body only 0.5 µm
and 5 µm particle are considered for maintain the clean room practice. (At rest condition)
EU
GMP
|
ISO 14644-1 cleanroom standards
|
US FED STD 209E cleanroom standards
|
Metric
System
|
maximum particles/ft3
≥0.5 µm
|
maximum particles/m3
≥0.5 µm
|
Grade A
Grade B
Grade C
Grade D
|
ISO
5
ISO 5
ISO
7
ISO
8
|
100
Class
100 Class
10000 Class
100000 Class
|
M
3.5
M
4.5
M
5.5
M
6.6
|
100
100
10000
100000
|
3520
3520
352000
3520000
|
Fed Std. 209 E USA (per cubic foot)
ISO standard requires results to be shown in cubic meters (1 cubic meter = 35.314 cubic feet)
So no difference
between 100 Class room and ISO 5 or Grade A, these words are used for same
principle.
Reference:
1. WHO TRS 961 , annex. 6 (http://apps.who.int/medicinedocs/documents/s19959en/s19959en.pdf)
2. EU annex 1 (http://ec.europa.eu/health//sites/health/files/files/eudralex/vol-4/2008_11_25_gmp-an1_en.pdf)
3. USFDA aseptic guidance 2004 (http://www.fda.gov/downloads/Drugs/.../Guidances/ucm070342.pdf)
Reference:
1. WHO TRS 961 , annex. 6 (http://apps.who.int/medicinedocs/documents/s19959en/s19959en.pdf)
2. EU annex 1 (http://ec.europa.eu/health//sites/health/files/files/eudralex/vol-4/2008_11_25_gmp-an1_en.pdf)
3. USFDA aseptic guidance 2004 (http://www.fda.gov/downloads/Drugs/.../Guidances/ucm070342.pdf)
are these grades and counts latest as new records?
ReplyDelete